Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2014 / Cilt: 24 - Sayı: 1

A myasthenıa gravıs case wıth an unusual clınıc onset

Farklı bir klinik başlangıç gösteren miyastenia gravis olgusu

Pages
59–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After detailed investigations he is diagnosed as Myasthenia Gravis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myasthenia Gravis (MG) is a neuromuscular junction disease and rare in childhood.
📊
Key Findings & Data:The clinical symptoms mostly begin in eye muscles with ptosis.
💡
Conclusion & Impact:After detailed investigations he is diagnosed as Myasthenia Gravis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myasthenia Gravis (MG) is a neuromuscular junction disease and rare in childhood. The clinical symptoms mostly begin in eye muscles with ptosis. Therefore, without ptosis there may be delays in diagnosis or the patients may be misdiagnosed. In this case a five year old boy who was diagnosed and treated as Miller-Fisher syndrome (MFS) with the signs of difficulty in walking and strabismus, admitted to our clinic with same complaints. After detailed investigations he is diagnosed as Myasthenia Gravis.

Özet

Bir nöromuskuler bileşke hastalığı olan Miyastenia Gravis (MG) çocukluk çağında nadir görülür. Klinik bulgular çoğunlukla göz kaslarında başlar ve kendini ptozis ile belli eder. Bu nedenle ptozisi olmayan olgularda tanıda gecikmeler veya yanlış tanılar olabilir. Yürüme zorluğu ve gözlerde kayma yakınmalarıyla Miller-Fisher (MFS) sendromu olarak değerlendilerek tedavi edilen fakat şikayetlerinin gerilememesi nedeniyle yapılan değerlendirmede Miyastenia Gravis tanısı alan 5 yaşında erkek olgu sunulmuştur.

🔖

Cite This Article

TANRISEVER, Ö., SARIOĞLU, B., KANIK, M. A., ARSLAN, C. N., BAYDAN, F. (2014). A myasthenıa gravıs case wıth an unusual clınıc onset. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 24 - Sayı: 1, 59–62. https://ajindex.com/articles/216319

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. McGrogan A, Sneddon S, Vries CS. The incidence of Myasthenia Gravis: a systematic literature review. Neuroepidemiology 2010; 34(3):171-83. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004 Apr; 29(4): 484-505.
  2. Rodriguez M, Gomez MR, Howard FM, Taylor WF. Myasthenia gravis in children: long-term follow-up. Ann Neurol 1983 May; 13(5): 504-10.
  3. Anlar B, Senbil N, Köse G, Değerliyurt A. Serological follow- up in juvenile myasthenia: clinical and acetylcholine receptor antibody status of patients followed for at least 2 years. Neuromuscul Disord 2005 May; 15(5): 355-7. Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 2007 Nov; 36(5): 615-27. Sarnat H. Disorders of Neuromuscular Transmission and of Motor Neurons. In: Kliegman RM, Stanton BF, Schor NF, St. Geme JW, Behrman RE. Nelson Textbook of Pediatrics, 19th edition. Philadelphia. W.B.Saunders Company, 2011: 2132-8.
  4. Değerliyurt A, Şenbil N, Anlar B. Jüvenil (otoimmün) miyasteni: Klinik özellikler ve tedavi sonuçları. Coc Sag Hast Derg 2005; 25–9. Pitt M. Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children. Dev Med Child Neuro 2008 May; 50(5): 328-33. Anlar B. Juvenile myasthenia: diagnosis and treatment. Paediatr Drugs 2000; 2: 161- 9. Saltık S, Ergüven M, Turgut T, Demirbilek V, Özümüztoprak N. Çocukluk çağında Miyastenia Gravis. Türk Pediatri Arşivi 2004; 39: 135-8.
  5. Sri-udomkajorn S, Panichai P, Liumsuwan S. Childhood myasthenia gravis: clinical features and outcomes. J Med Assoc Thai 2011 Aug; 94(3): 152-7.
  6. Thanvi BR, Lo TC. Update on myasthenia gravis. Postgrad Med J 2004 Dec; 80(950):690-700 Küsbeci T,Küsbeci ÖY,Yavaş G,Öztürk F. Oküler Myastenia Gravisli Pediatrik Bir Olgu. Turkiye Klinikleri J Ophthalmol 2008;17(3):214-8.